New York, NY -- (SBWire) -- 02/12/2019 --Some of the major players in the molecular diagnostics market include Bio-Rad Laboratories, Inc.; Bayer AG; Siemens Healthcare GmbH; Abbott; Alere, Inc.; Danaher; Dickinson and Company; Dako; Hologic, Inc. (Gen probe); Novartis AG; Sysmex Corporation; Qiagen N.V.; Johnson & Johnson; Becton, Roche Diagnostics; bioMerieux SA; and Cepheid among others.
Download FREE PDF Sample Brochure @ https://www.marketindustryreports.com/pdf/10
Market Industry Reports (MIR) has published a new report titled "Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report the global molecular diagnostics market was valued at over US$ 6 Bn in 2017 and is expected to grow at a double digit in the forecasted period. The growth of this market can be attributed to the factors such as, growing number of infectious diseases, hospital acquired infections and various other diseases.
Molecular diagnostics is a vital tool for the cost-effective, accurate, rapid, delivery of effective and safe therapy for many diseases. Increasing cases of hospital acquired infections and (add more drivers) have led to the growing need for molecular diagnostic in hospitals facilities. According to Centers for Disease Control (CDC) in 2017, Hospitals Acquired Infections (HAI) accounted for almost 1.7 million cases with 99,000 deaths every year in the U.S.
Browse key industry insights spread across 150 pages with market data tables & figures & charts from the report, Molecular Diagnostics Market by Product & Services (Reagents & Kits, Instruments, Services) Technique (PCR, Sequencing, Electrophoresis), End Users (Diagnostic & Research laboratories, Pharmaceutical & Bio Technique Companies) and Region - Global Analysis & Forecast 2019-2030 in detail along with the table of contents: https://www.marketindustryreports.com/10/molecular-diagnostics-market
Increasing Government Grants to Boost the Market
Increasing funding by governments and various organizations for research and clinical studies in the molecular diagnosis space are anticipated to boost the market growth. These initiatives by the government play an important role in the practice of new product development. For instance, Accelerate Diagnostics received a funding of USD 19.45 million by different organizations, including the Oracle Institutional Partners, Schuler Family Foundation, Oracle Partners, & various others, for development and sale of IVD tests and tools. Moreover, in 2015, Merck's venture capital arm funded AdvanDx with almost USD 12 million for R&D of pathogen screening for key HAI.
Technology Advancements; Creating Newer Opportunities
Technological advancements in the field of molecular diagnostics are expected to drive the market as they allow greater portability, accuracy, and cost-effectiveness. For instance, the introduction of MinION, by Nanopore Technologies offers an affordable and portable sequencer, catering to the users in point-of-care facilities and small peripheral laboratories, which is expected to boost the growth of global molecular diagnostics market.
Similarly, better throughput, improvement in nanotechnology and the introduction of point of care devices are supporting the growth molecular diagnostics as a transformative procedure
Download FREE PDF Sample Brochure @ https://www.marketindustryreports.com/sample/10
Region wise performance of the Molecular Diagnostics industry
This report studies the global Molecular Diagnostics market status and forecast, categorizes the global Molecular Diagnostics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
The Research Provides Answers to the Following Key Questions:
- What is the size of occupied by the prominent leaders for the forecast period, 2019 to 2030? What will be the share and the growth rate of the Molecular Diagnostics Market during the forecast period?
- Which companies are dominating the competitive landscape across different region and what strategies have they applied to gain a competitive edge?
- What are the major factors responsible for the growth of the Molecular Diagnostics market across the different regions?
- What are the challenges faced by the companies operating in the Molecular Diagnostics Market?
- What are the future prospects for the Molecular Diagnostics Market industry in the coming years?
- Which trends are likely to contribute to the development rate of the Molecular Diagnostics industry during the forecast period, 2019 to 2030?
- What are the future prospects of the Molecular Diagnostics industry for the forecast period, 2019 to 2030?
Purchase Molecular Diagnostics Market Research Report@ https://www.marketindustryreports.com/checkout/10
About Market Industry Reports
A global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
Contact us :
502, Sai Radhe, Kenedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune-411001,
Maharashtra, India.
sales@marketindustryreports.com
+ 91 8956 767 535
Molecular Diagnostics Market Trends by 2030: Top Players Like Bio-Rad Laboratories, Bayer AG, Abbott, Danaher, Novartis AG; Sysmex Corporation, bioMerieux SA
Technological advancements in the field of molecular diagnostics are expected to drive the market as they allow greater portability, accuracy, and cost-effectiveness. For instance, the introduction of MinION, by Nanopore Technologies offers an affordable and portable sequencer, catering to the users in point-of-care facilities and small peripheral laboratories, which is expected to boost the growth of global molecular diagnostics market.